4 active warrant series covering 12,006,192 shares (~5.4% potential dilution); nearest expiry 2026-12-15.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.80 | Dec 15, 2026 76d | 6.4M | OTM | 2.9% | C$5.1M | Auto |
| warrant | $0.90 | Dec 15, 2026 76d | 1.2M | OTM | 0.5% | C$1.1M | Auto |
| warrant | $0.50 | Jun 20, 2027 263d | 1.3M | OTM | 0.6% | C$647K | Auto |
| warrant | $0.55 | Jun 20, 2027 263d | 3.1M | OTM | 1.4% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 14,750,000 shares (~6.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.56 | Jan 7, 2027 99d | 3.5M | OTM | 1.6% | C$1.9M | Auto |
| option | $0.45 | Jan 24, 2028 481d | 3.5M | OTM | 1.6% | C$1.6M | Auto |
| option | $0.59 | Feb 2, 2029 856d | 4.0M | OTM | 1.8% | C$2.4M | Auto |
| option | $0.40 | Feb 10, 2030 1229d | 3.5M | OTM | 1.6% | C$1.4M | Auto |
| option | $0.45 | Mar 24, 2031 1636d | 300K | OTM | 0.1% | C$135K | Auto |
221,298,210 shares outstanding, plus 12,006,192 from warrants and 14,750,000 from options — a fully diluted 248,054,402 shares, or ~12.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series covering 12,006,192 shares (~5.4% potential dilution); nearest expiry 2026-12-15.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.80 | Dec 15, 2026 76d | 6.4M | OTM | 2.9% | C$5.1M | Auto |
| warrant | $0.90 | Dec 15, 2026 76d | 1.2M | OTM | 0.5% | C$1.1M | Auto |
| warrant | $0.50 | Jun 20, 2027 263d | 1.3M | OTM | 0.6% | C$647K | Auto |
| warrant | $0.55 | Jun 20, 2027 263d | 3.1M | OTM | 1.4% | C$1.7M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
5 option grants covering 14,750,000 shares (~6.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.56 | Jan 7, 2027 99d | 3.5M | OTM | 1.6% | C$1.9M | Auto |
| option | $0.45 | Jan 24, 2028 481d | 3.5M | OTM | 1.6% | C$1.6M | Auto |
| option | $0.59 | Feb 2, 2029 856d | 4.0M | OTM | 1.8% | C$2.4M | Auto |
| option | $0.40 | Feb 10, 2030 1229d | 3.5M | OTM | 1.6% | C$1.4M | Auto |
| option | $0.45 | Mar 24, 2031 1636d | 300K | OTM | 0.1% | C$135K | Auto |
221,298,210 shares outstanding, plus 12,006,192 from warrants and 14,750,000 from options — a fully diluted 248,054,402 shares, or ~12.1% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
